Archive: 04/10/2017
Abbott wins FDA approval for diabetes device that doesn't require routine finger pricks
Abbott Laboratories has gained clearance to start selling in the U.S. the first continuous glucose monitor that does not require people with diabetes to routinely prick their fingers.
Oct 4, 2017
Out-of-pocket costs often keep pricey new cholesterol drugs out of reach, study finds
Access to powerful new cholesterol-lowering drugs is so tightly controlled and patients' out-of-pocket costs are so high that fewer than a third of people whose doctors prescribe the drugs get them, a new study found.
Oct 4, 2017